Condition: Growth Hormone Deficiency · Sponsor: AEterna Zentaris
This research study will find out if a new growth hormone stimulation test is safe and works as well as other tests to diagnose growth hormone deficiency (GHD) in children. The stimulation test will use a new growth hormone stimulating substance called macimorelin. By now, only adults in the USA can get this new stimulation test. The results of this study are expected to help children and teenagers with suspected GHD to get the macimorelin stimulation test. The macimorelin test will be compared to a clonidine and an arginine test. Both are known standard stimulation tests. Altogether two macimorelin tests are planned to be performed in the study, to show how repeatable macimorelin tests results are (under a set of similar conditions).
This description comes directly from the study's public registry record.
Contact details are listed per location below or on the registry record.
Always discuss trial participation with your own doctor first.
| Angel Wing Clinic For Children With Diabetes | Tucson, Arizona, United States | — |
| Pediatric Endocrine Associates, p.c. | Greenwood Village, Colorado, United States | — |
| John Hopkins All Children's Hospital | St. Petersburg, Florida, United States | — |
| Emory Healthcare-Children's Center | Atlanta, Georgia, United States | — |
| St. Luke's Children's Endocrinology | Boise, Idaho, United States | — |
| University of Minnesota, Masonic Children's Hospital | Minneapolis, Minnesota, United States | — |
| The Children's Mercy Hospital - Broadway | Kansas City, Missouri, United States | — |
| Icahn School of Medicine at Mount Sinai | New York, New York, United States | — |
| Children's Hospital at Montefiore | The Bronx, New York, United States | — |
| UNC Hospitals | Chapel Hill, North Carolina, United States | — |
| Alchemi Research Center | Rosharon, Texas, United States | — |
| Multicare Health System | Tacoma, Washington, United States | — |
+ 33 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04786873